STORY FROM: Talcum Powder Litigation Report
J&J Defendants File Reply Brief in Appeal of Order Tossing $417 Million Talc Verdict
April 10, 2019
LOS ANGELES –– Johnson & Johnson defendants have filed a brief defending a trial court order tossing a $417 million verdict in an ovarian cancer talcum powder case, maintaining that there is only a weak statistical association between talc and ovarian cancer.
In a reply brief on cross-appeal filed March 6 in the California Second District Court of Appeal, Division Three, Johnson & Johnson and Johnson & Johnson Consumer Inc. stressed that, under negligence principles, “manufacturers are not required to warn of dangers that possibly exist, only of those dangers that probably do exist, as established in the then-existing ...